18F-FASu 流入速率反映肿瘤异种移植瘤中胱氨酸/谷氨酸逆向转运体表达
本研究在四种肿瘤异种移植瘤小鼠模型中,比较动态 18F-FASu 与 18F-FDG PET 摄取与转运体表达的关系。药代动力学模型显示 18F-FASu 的流入速率 K1 与 xCT 水平显著相关(p = 0.001),且显著高于 18F-FDG 的 K1(p < 0.001)。结论认为 18F-FASu 流入速率反映肿瘤异种移植瘤中 xCT 活性。
要点
- 18F-FASu 的 K1 与 xCT 表达显著相关(p = 0.001),且高于 18F-FDG 的 K1(p < 0.001)。
- 18F-FDG 的 K1 与 GLUT1 表达显著相关(p = 0.002)。
- 18F-FASu 与 18F-FDG 估计的 vB 高度一致且显著相关(r = 0.85,p < 0.001)。
核心结论
- 18F-FASu 的流入速率反映肿瘤异种移植瘤中 xCT 活性。
- 需动态 PET 及药代动力学建模才能全面评估 18F-FASu 的分布途径。
研究设计与样本
- 在雌性无胸腺裸鼠中植入四种肿瘤异种移植瘤系:MAS98.12 和 HBCx3(乳腺)、TPMX(骨肉瘤)、A549(肺)。
- 使用小动物 PET 设备进行 60 分钟动态 PET 扫描。
- 从个体肿瘤的时间-活性曲线提取早期(SUVE,注射后 2 分钟)和晚期(SUVL,注射后 55 分钟)标准化摄取值。
- 对时间-活性曲线应用药代动力学二室模型估计速率常数 K1-k4 和血容量分数 vB。
- 用蛋白质印迹法评估 xCT 相对水平,用免疫组化评估 GLUT1 和 CD31 表达。
主要发现
- 18F-FASu 显示较高的 SUVE,而 18F-FDG 显示较高的 SUVL。
- 18F-FASu 的流入速率 K1 与 xCT 水平显著相关(p = 0.001),且显著高于 18F-FDG 的 K1(p < 0.001)。
- 18F-FDG 的 K1 与 GLUT1 水平显著相关(p = 0.002)。
- 由 18F-FASu 和 18F-FDG 时间-活性曲线估计的 vB 高度一致且显著相关(r = 0.85,p < 0.001)。
- 识别出两种定性不同的 18F-FASu 摄取模式:α 型为低 xCT 表达和低 K1(A549 和 HBCx3),β 型为高 xCT 表达和高 K1(MAS98.12 和 TPMX)。
临床怎么用
- 18F-FASu 动态 PET 联合药代动力学建模可用于评估肿瘤 xCT 表达水平。
- 18F-FASu 的 K1 参数可能作为反映 xCT 活性的影像生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: 18F-fluoroaminosuberic acid (18F-FASu) is a recently developed amino acid tracer for positron emission tomography (PET) of oxidative stress that may offer improved tumour assessment over the conventional tracer 18F-fluorodeoxyglucose (18F-FDG). Our aim was to evaluate and relate dynamic 18F-FASu and 18F-FDG uptake with pharmacokinetic modelling to transporter protein expression levels in a panel of diverse tumour xenograft lines. METHODS: Four different tumour xenograft lines were implanted in female athymic nude mice: MAS98.12 and HBCx3 (breast), TPMX (osteosarcoma) and A549 (lung). Dynamic PET over 60 min was performed on a small animal unit. The time-activity curves (TACs) for 18F-FASu and 18F-FDG in individual tumours were used to extract early (SUVE; 2 min p.i.) and late (SUVL; 55 min p.i.) standardised uptake values. Pharmacokinetic two-tissue compartment models were applied to the TACs to estimate rate constants K1-k4 and blood volume fraction vB. Relative levels of cystine/glutamate antiporter subunit xCT were assessed by western blotting, and expression of GLUT1 and CD31 by immunohistochemistry. RESULTS: 18F-FASu showed higher SUVE, whilst 18F-FDG exhibited higher SUVL. Influx rate K1 for 18F-FASu was significantly correlated with xCT levels (p = 0.001) and was significantly higher than K1 for 18F-FDG (p < 0.001). K1 for 18F-FDG was significantly correlated with GLUT1 levels (p = 0.002). vB estimated from 18F-FASu and 18F-FDG TACs was highly consistent and significantly correlated (r = 0.85, p < 0.001). Two qualitatively different 18F-FASu uptake profiles were identified: type α with low xCT expression and low K1 (A549 and HBCx3), and type β with high xCT expression and high K1 (MAS98.12 and TPMX). CONCLUSION: The influx rate of 18F-FASu reflects xCT activity in tumour xenografts. Dynamic PET with pharmacokinetic modelling is needed to fully appraise 18F-FASu distribution routes.
引用
- Pitman KE, Alluri SR, Kristian A, et al. Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts. Eur J Nucl Med Mol Imaging. 2019. PMID: 31264167. doi:10.1007/s00259-019-04375-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。